Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.

The shot protects against five strains of Neisseria meningitidis, eliminating the need for multiple vaccines. ACIP voted on the new recommendations during an April 15-16 meeting. The guidance is ...

It is indicated in the US for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in individuals aged 10 through 25 years. GSK’s MenB vaccine ...

Meningococcal disease is a severe, fast-progressing infection; vaccination is key for high-risk groups, preventing ...

GSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...

It noted that cerebrospinal meningitis is a life-threatening infection of the brain and spinal cord caused by Neisseria meningitidis bacteria. According to experts, it spreads through coughing ...

of the bacteria Neisseria meningitidis. MenABCWY covers five of the six serogroups that cause most disease worldwide, with the B, C, and Y strains responsible for most cases of invasive ...

Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.55 per share now. ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn ...

In a statement, the FDA said Bkemv has been approved with the same boxed warning for increased risk of serious and life-threatening meningococcal infections caused by Neisseria meningitidis that ...

Having Neisseria meningitidis, one bacterial cause of meningitis, in your bloodstream may cause a faint rash. Bacteria from a meningococcal meningitis infection reproduce in the blood and target ...